Aptamer-siRNA Chimera Targeting RORgammat in Th17 Cells for Topical Therapy of Psoriasis
OHSU # 1896
Researchers at Oregon Health & Science University and at the Portland VA Medical Center have discovered and validated a novel aptamer-siRNA chimera targeting RORgammat in Th17 cells for topical treatment of psoriasis. If interested in learning more, please contact the Office of Technology Transfer and Business Development (firstname.lastname@example.org) and reference Tech Id No. 1896.
Other Patents Filed
For more information, contact:
Senior Technology Development Manager